Literature DB >> 3489378

Lumbar herniated disk disease and canal stenosis: prospective evaluation by surface coil MR, CT, and myelography.

M T Modic, T Masaryk, F Boumphrey, M Goormastic, G Bell.   

Abstract

Sixty patients with suspected lumbar herniated disk and/or canal stenosis were studied prospectively with surface coil MRI, CT, and/or myelography, and the results were compared with the surgically confirmed abnormality. Forty-eight patients had lumbar surgery at 62 levels. There were no negative explorations. Thirty-nine patients had a myelogram and CT. Thirty of the CTs were performed following the injection of metrizamide for myelography. Nine patients had a CT without intrathecal contrast material 1 to several days before the myelogram. Six patients had myelography only, and three patients had CT only. All studies were evaluated for the location and type of disease in a forced choice fashion. Independent of the surgically correlated levels, there was 86.8% agreement between the MR and CT studies in all patients at 151 levels and 87.2% agreement between MR and myelography at 218 levels. At the operative levels, there was 82.6% agreement between MR and surgical findings for both type and location of disease; 83% agreement between CT and surgical findings; and 71.8% agreement between myelography and surgical findings. There was 92.5% agreement when MR and CT were used jointly, and 89.4% agreement when CT and myelography were used jointly. The results of this study indicate that a technically adequate MR examination was equivalent to CT and myelography in the diagnosis of lumbar canal stenosis and herniated disk disease. CT and MR can be complementary studies, and surface coil MR can be viewed as an alternative to myelography.

Entities:  

Mesh:

Year:  1986        PMID: 3489378     DOI: 10.2214/ajr.147.4.757

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  28 in total

1.  Myelography: still the gold standard.

Authors:  Gary M Miller; William E Krauss
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

2.  [MRT diagnosis for degenerative changes in the spine].

Authors:  T Kahn; U Quäschling; V Engelbrecht
Journal:  Radiologe       Date:  2004-08       Impact factor: 0.635

3.  Comparison of myelography combined with postmyelographic spinal CT and MRI in suspected metastatic disease of the spinal canal.

Authors:  S Helweg-Larsen; A Wagner; L Kjaer; A Johnsen; J Boesen; T Palner; P S Sørensen
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

4.  A new grading system of lumbar central canal stenosis on MRI: an easy and reliable method.

Authors:  Guen Young Lee; Young Lee Guen; Joon Woo Lee; Woo Lee Joon; Hee Seok Choi; Seok Choi Hee; Kyoung-Jin Oh; Oh Kyoung-Jin; Heung Sik Kang; Sik Kang Heung
Journal:  Skeletal Radiol       Date:  2011-02-01       Impact factor: 2.199

5.  Low back pain.

Authors:  W G Bradley
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

6.  Anatomy of lumbar radicular compression: anatomic and radiological thoughts about failures of decompressive surgery.

Authors:  J Y Lazennec; B Rogen; N Moral; H Guerin-Survillel; G Saillant
Journal:  Eur J Orthop Surg Traumatol       Date:  1996-05

Review 7.  Clinical efficacy of imaging modalities in the diagnosis of low-back pain disorders.

Authors:  N Boos; P H Lander
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

8.  Three-dimensional MR myelography of the lumbar spine: comparative case study to X-ray myelography.

Authors:  K E Eberhardt; H P Hollenbach; B Tomandl; W J Huk
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

9.  Surgical treatment and results in patients suffering from lumbar spinal stenoses.

Authors:  M Lange; C Hamburger; E Waidhauser; O J Beck
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

10.  An atypical psoriatic spondylitis case, successfully treated with methotrexate.

Authors:  C Tüzün; O Peker; F Küçüktaş; S Gülbahar; I Kovanlikaya; S Füzün
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.